Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Correlation established between serum PLA2 activity and schizophrenia symptoms

Aug. 30, 1996

Potential antipsychotic described by Parke-Davis

Aug. 30, 1996

Famotidine tested in schizophrenic patients

Aug. 30, 1996

DuPont Merck reports on CRH antagonists for anxiety, depression

Aug. 30, 1996

Russian investigators describe new tranquilizer

Aug. 30, 1996

BMS, Sano to collaborate on transdermal BuSpar development

Aug. 30, 1996

Flunitrazepam may alter circadian sleep-wake rhythms

Aug. 30, 1996

Merck & Co. reports NK1 antagonists

Aug. 30, 1996

Lidocaine topical patch effective in treating post-herpetic neuralgia

Aug. 30, 1996

Potential tachykinin NK1 antagonists from Merck & Co.

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...